ARCHIVES

Grant, contract Awards Held Up By Impasse On Appropriations

This article is from The Cancer Letter archive.

Vol. 03 No. 41 | October 14, 1977

Download PDF Visit The Full Archive

Related Articles

House Bill Seeks Coverage for Care Planning, Reviving Proposal Once Maligned By The Right

September 6, 2013

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975